COMMUNIQUÉS West-GlobeNewswire
-
Emergent BioSolutions Joins Effort to Combat National Public Health Threat From Opioid Overdose Through Acquisition of Adapt Pharma and Its Flagship Product NARCAN® (naloxone HCl) Nasal Spray
28/08/2018 - 22:31 -
Flexion Therapeutics to Present at the 2018 Wells Fargo Healthcare Conference
28/08/2018 - 22:30 -
SeaSpine to Participate in the 13th Annual Wells Fargo Securities Healthcare Conference
28/08/2018 - 22:05 -
Emisphere’s Proprietary Eligen Technology Supports Novo Nordisk’s Oral Semaglutide
28/08/2018 - 22:05 -
Novavax to Participate at Two Upcoming Investor Conferences
28/08/2018 - 22:05 -
Merit Medical to Present at Three Upcoming Conferences
28/08/2018 - 22:01 -
Endocyte Announces Presentations at the CAR-TCR Summit 2018
28/08/2018 - 22:01 -
Kiniksa Pharmaceuticals to Present at the 2018 Wells Fargo Healthcare Conference
28/08/2018 - 22:01 -
Cross-Disciplinary Healthcare Leaders Convened for NRC Health Symposium in San Diego
28/08/2018 - 20:29 -
Kaiser Permanente Woodland Hills Medical Center recognized for exceptional commitment to improving healthcare outcomes
28/08/2018 - 20:20 -
Distribution of ZRx Prescriber and KDA Group
28/08/2018 - 19:58 -
Distribution du prescripteur ZRx et Groupe KDA
28/08/2018 - 19:58 -
Ritter Pharmaceuticals to Present at 20th Annual HC Wainwright Global Investment Conference on September 5, 2018
28/08/2018 - 19:31 -
Abattis Prepares to Launch New Products Through Vergence Naturals
28/08/2018 - 18:41 -
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
28/08/2018 - 18:17 -
Voyager Therapeutics to Present at Investor Conferences in September
28/08/2018 - 17:53 -
VIFOR PHARMA ISSUES INAUGURAL CHF 465 MILLION BOND
28/08/2018 - 17:52 -
Erin Engel, DPM is Appointed to the American Health Council’s Board of Physicians
28/08/2018 - 17:12 -
Virbac : Declaration of the number of shares and voting rights as of July 2018, 31.
28/08/2018 - 17:12
Pages